Esperion to Participate in Upcoming September Investor Conferences
August 30 2022 - 8:00AM
Esperion (NASDAQ: ESPR) today announced that President and CEO,
Sheldon Koenig, will present at Morgan Stanley’s 20th Annual Global
Healthcare Conference and also participate in H.C. Wainwright’s
Annual Global Investment Conference.
Event: |
Morgan Stanley 20th Annual Global Healthcare Conference |
Date: |
Monday, September 12th, 2022 |
Time: |
9:20 AM (ET) |
Format: |
Presentation and 1:1 Meetings |
Webcast: |
Link |
Event: |
H.C. Wainwright Annual Global Investment Conference |
Date: |
September 12-14, 2022 |
Time: |
Presentation on Sept 13, 11:30 AM (ET) |
Format: |
Presentation and 1:1 Meetings |
Webcast |
Link |
A live audio webcast can be accessed on the investor and media
section of the Esperion website at
https://www.esperion.com/investor-relations/events. Access to the
webcast replay will be available approximately two hours after
completion of the call and will be archived on the Company’s
website for approximately 90 days.
Esperion TherapeuticsEsperion works hard to
make our medicines easy to get, easy to take and easy to have. We
discover, develop, and commercialize innovative medicines and
combinations to lower cholesterol, especially for patients whose
needs aren’t being met by the status quo. Our entrepreneurial team
of industry leaders is inclusive, passionate and resourceful. We
are singularly focused on managing cholesterol so you can improve
your health easily. Esperion commercializes NEXLETOL® (bempedoic
acid) and NEXLIZET® (bempedoic acid and ezetimibe) Tablets and is
the leader in the development of convenient oral, once-daily
non-statin LDL-cholesterol lowering drugs for patients with high
levels of bad cholesterol. For more information, please visit
www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Contact:Esperion Corporate
Communicationscorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024